2009
DOI: 10.1586/epr.09.45
|View full text |Cite
|
Sign up to set email alerts
|

Venomics as a drug discovery platform

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
115
0
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 158 publications
(117 citation statements)
references
References 31 publications
0
115
0
2
Order By: Relevance
“…Considering that around 44,000 terrestrial venomous species (scorpions, snakes, spiders), 20,000 marine species (cone snails, turrids, and Cnidarians) and 103,000 flying species (hymenopterans) have already been reported, and that each of their venoms is composed of approximately 250 different toxins, this natural pool consists of more than 40 million peptide toxins, biochemically stable and with particular pharmacologic properties [1,2]. From this impressive number of toxins, only 1600 have been identified corresponding to less than 0.01% of the whole bank.…”
Section: Introductionmentioning
confidence: 99%
“…Considering that around 44,000 terrestrial venomous species (scorpions, snakes, spiders), 20,000 marine species (cone snails, turrids, and Cnidarians) and 103,000 flying species (hymenopterans) have already been reported, and that each of their venoms is composed of approximately 250 different toxins, this natural pool consists of more than 40 million peptide toxins, biochemically stable and with particular pharmacologic properties [1,2]. From this impressive number of toxins, only 1600 have been identified corresponding to less than 0.01% of the whole bank.…”
Section: Introductionmentioning
confidence: 99%
“…Only full tryptic peptides were considered with a maximum of two missed cleavages. Mass tolerances for MS 1 and MS 2 were set at 70 and 550 ppm, respectively. XCorr was determinate as a primary score, and ZScore was used as a secondary one.…”
Section: Methodsmentioning
confidence: 99%
“…The toxic secretions of venomous animals have long been a source of biologically active molecules, yet remain a promising source of new drugs (1,2). Snake venoms in particular are widely studied and contain a mixture of small molecules, peptides, proteins, and protein complexes which are used to incapacitate prey and to defend against predators (3)(4)(5).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Utilising these new and improved techniques has significantly increased our understanding of the remarkable venom complexity of several jellyfish species [14] (see chapter 3 and 4). When genomic database (and therefore theoretical protein databases) is not available, activity-guided fractionation can be useful to facilitate characterisation of active toxins (bioactivies) in whole venom [146,285]. For example, screening of the fractioned crude venom from Conus sp.…”
Section: Introductionmentioning
confidence: 99%